Authors
-
Bandhu Ivnati, Manas Thakre*, Gaurav Rewatkar, Akansha Bhandarkar
Abstract
Ciprofloxacin is one of the most popular antibiotics in its class because it’s available in the brand product as well as several generic products, and is used for treatments for bacterial infection. Of these Ciprofloxacin versions, the clinical decisions depend upon pharmacoeconomic and therapeutic nuances for which the healthcare professionals are the key. Branded ciprofloxacin is more expensive compared to generic ciprofloxacin, and therefore, this would result in better value for money for the patient as well as healthcare, thus making treatment-of-pharmaceuticals more affordable and also opening up access to pharmaceutical treatment in resource constrained regions. Bioavailability differences, inactive ingredients and manufacturing quality issues that occur during generic ciprofloxacin rating can affect patient adherence as well as therapeutic outcomes. In this study, the economic aspects, together with regulatory processes and clinical performance of brand name ciprofloxacin versus generic equivalent is analyzed. Generic drugs are required by the FDA and EMA to show bioequivalence standard through regulatory inspection despite the continued effect of changes in formulation and patient perception on prescribing practice. Market selection toward generics is driven by market dynamics in the pharmaceutical marketing and also by the insurance reimbursement regulations. Generic ciprofloxacin is available and appears to provide as good effectiveness and safety as the original. The research outcomes show that development by healthcare practitioners and patients’ understanding of generic medicines reliability. Future research pertaining to the pharmacokinetic variations and patient medication commitment should establish confidence in generic ciprofloxacin as a treatment alternative, considering clinical outcomes. Responsible antibiotic practice policies implementing cost effective prescribing to combat antibiotic resistance leads to healthcare sustainability.